Service d'anesthésie, de Médecine Intensive, de Médecine péri-opératoire et de Réanimation Hospices Civils de Lyon Groupement Sud, Lyon, France; REA-REZO (Surveillance, Infections & Antibiotic Resistance Network in ICU), Hospices Civils de Lyon Groupement Sud, St Genis Laval, France; Public Health, Epidemiology and Evolutionary Ecology of Infectious Diseases, Centre International de Recherche en Infectiologie Lyon, France.
REA-REZO (Surveillance, Infections & Antibiotic Resistance Network in ICU), Hospices Civils de Lyon Groupement Sud, St Genis Laval, France; CPias Auvergne Rhône-Alpes, Hôpital Henry Gabrielle, Hospices Civils de Lyon, France.
Clin Microbiol Infect. 2023 Apr;29(4):530-536. doi: 10.1016/j.cmi.2022.10.023. Epub 2022 Oct 28.
To compare the occurrence of healthcare-associated infections acquired in intensive care units (HAI-ICUs) in France among patients with COVID-19 and those without it in 2020 and the latter with that in patients before the COVID-19 pandemic.
Multicentre HAI-ICU surveillance network (REA-REZO) data were used to identify 3 groups: 2019 patients (2019Control), a COVID-19 group (2020Cov), and a non-COVID-19 group (2020NonCov). The primary outcome was the occurrence of HAI-ICU (ventilator-associated pneumonia [VAP], bloodstream infections [BSIs], catheter-related bacteraemia). Standardized infection ratios of VAP were calculated for each quarter in 2020 and compared with those in 2019.
A total of 30 105 patients were included in 2020: 23 798 in the 2020NonCov group, 4465 in 2020Cov group, and 39 635 patients in the 2019Control group. The frequency of VAP was strikingly greater in the 2020Cov group: 35.6 (33.4-37.8) episodes/1000 days of mechanical ventilation versus 18.4 (17.6-19.2) in the 2020NonCov group. VAP standardized infection ratio was high in 2020 patients, particularly during the 2 quarters corresponding to the 2 waves. BSI/1000 days were more frequent in the 2020Cov group (6.4% [6.4-6.4%] vs. 3.9% [3.8-3.9%] in the 2020NonCov group). VAP and BSI were also more frequent in the 2020NonCov group than in the 2019Control group. The microbial epidemiology was only slightly different.
The data presented here indicate that HAI-ICUs were more frequent during the COVID-19 period, whether the patients were admitted for COVID-19 or, to a lesser extent, for another cause. This implies that managing patients with severe disease in a pandemic context carries risks for all patients.
比较 2020 年法国重症监护病房(ICU)中 COVID-19 患者与非 COVID-19 患者获得的与医疗保健相关的感染(HAI-ICU)的发生率,并将后者与 COVID-19 大流行前的患者进行比较。
使用多中心 HAI-ICU 监测网络(REA-REZO)的数据,确定了 3 组患者:2019 年患者(2019Control)、COVID-19 组(2020Cov)和非 COVID-19 组(2020NonCov)。主要结局是 HAI-ICU(呼吸机相关性肺炎[VAP]、血流感染[BSI]、导管相关菌血症)的发生情况。计算了 2020 年每一季度的 VAP 标准化感染比,并与 2019 年进行了比较。
共纳入 30105 例患者,其中 2020 年 23798 例患者在 2020NonCov 组,4465 例患者在 2020Cov 组,39635 例患者在 2019Control 组。2020Cov 组的 VAP 发生率明显更高:机械通气 1000 天 35.6(33.4-37.8)例/1000 天,2020NonCov 组为 18.4(17.6-19.2)例/1000 天。2020 年患者的 VAP 标准化感染比高,尤其是在对应于 2 波的 2 个季度。2020Cov 组的 BSI/1000 天更频繁(6.4%[6.4-6.4%]比 2020NonCov 组的 3.9%[3.8-3.9%])。2020NonCov 组的 VAP 和 BSI 也比 2019Control 组更频繁。微生物流行病学仅略有不同。
这里提供的数据表明,COVID-19 期间 HAI-ICU 更常见,无论患者是因 COVID-19 还是因其他原因入院。这意味着在大流行背景下管理重症患者对所有患者都存在风险。